VPC News

Researchers at the Vancouver Prostate Centre have developed Gemini, a novel self-amplifying nucleic acid platform designed to address key limitations of current mRNA technologies. The research, led by Professor Wilfred A. Jefferies, was recently published in Nature Communications. Gemini is a binary...

We are proud to share that Prostate Cancer Foundation Canada (PCFC) has announced the recipients of its 2026 Grant-in-Aid Awards, supporting initiatives that advance prostate cancer research, education, and community impact nationwide. This year, a high majority of the award recipients are...

Peter Black, Director of the Vancouver Prostate Centre, is leading research that applies advanced proteomic profiling to improve understanding of severe bladder cancers; an area of significant unmet clinical need. Bladder cancer is a biologically complex disease, particularly in its more aggressive...

We are proud to announce that Dr. Artem Cherkasov has been recognized as a 2025 Highly Cited Scientist by Clarivate. This prestigious distinction is awarded to only 24 researchers at the University of British Columbia and highlights exceptional research influence and citation impact worldwide. This...

View the publication online Advanced prostate cancer is usually treated by blocking male-hormone signaling through the androgen receptor (AR). Over time, many cancers learn to bypass these therapies by rewiring the AR gene itself. A new study published in Annals of Oncology (Virtanen et al., 2025)...

Dr. Wyatt will advance precision cancer diagnostics and treatments for people across B.C. and globally. The Faculty of Medicine is pleased to announce that Dr. Alexander Wyatt, a leading cancer genomics researcher, has been appointed the UBC President’s Excellence Chair in Precision Oncology. Dr...

Read more about the VCHRI-UBC feature showcasing the new baited-SELEX study. The feature, titled "DNA-guided platform paves way for more precise cancer treatments" is now available on the VCHRI website at https://www.vchri.ca/stories/2025/10/28/dna-guided-platform-paves-way-m…...

We’re thrilled to announce $14.5 million in new funding through the 2025 Terry Fox New Frontiers Program Project Grants (PPGs), supporting cutting-edge research in sarcomas, bladder cancer, high-risk brain cancer and immunotherapies. These multi-institutional teams are pushing the boundaries of...

We would like to acknowledge the following researchers who have been awarded Canadian Institutes of Health Research (CIHR) project grants in the latest funding competition. Each project has received five years of funding support: Drs. Artem Cherkasov and Natalie Strynadka, with co-investigators Drs...

Congratulations to Kerim Yavuz from Dr. Nathan Lack's laboratory in VPC on receiving the VCHRI 2025 Rising Star Award. This award celebrates the exceptional achievements of VCHRI trainees who demonstrate outstanding research excellence, leadership, and a meaningful impact on the Vancouver Coastal...